IL-29 Enhances CXCL10 Production in TNF-α-stimulated Human Oral Epithelial Cells

References

• Arpaci D, Karakas Celik S, Can M, et al. (2016). Increased serum levels of IL-28 and IL-29 and the protective effect of IL28B rs8099917 polymorphism in patients with Hashimoto’s thyroiditis. Immunol Invest, 45, 668–678.
   PubMed Web of Science ®Google Scholar
• Brand S, Beigel F, Olszak T, et al. (2005). IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol, 289, G960–G968.
   PubMed Web of Science ®Google Scholar
• Chen XT, Chen LL, Tan JY, et al. (2016). Th17 and Th1 lymphocytes are correlated with chronic periodontitis. Immunol Invest, 45, 243–254.
   PubMed Web of Science ®Google Scholar
• Gaffen SL, Hajishengallis G. (2008). A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res, 87, 817–828.
   PubMed Web of Science ®Google Scholar
• Guenterberg KD, Grignol VP, Raig ET, et al. (2010). Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis. Mol Cancer Ther, 9, 510–520.
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Bando M, Inagaki Y, et al. (2016). Effect of Hangeshashinto on calprotectin expression in human oral epithelial cells. Odontology, 104, 152–162.
   PubMed Web of Science ®Google Scholar
• Hosokawa I, Hosokawa Y, Shindo S, et al. (2016). Melatonin inhibits CXCL10 and MMP-1 production in IL-1β-stimulated human periodontal ligament cells. Inflammation, 39, 1520–1526.
   PubMed Web of Science ®Google Scholar
• Hosokawa Y, Hosokawa I, Ozaki K, et al. 2009. Cytokines differentially regulate CXCL10 production by interferon-gamma-stimulated or tumor necrosis factor-alpha-stimulated human gingival fibroblasts. J Periodontal Res, 44, 225–231.
   PubMed Web of Science ®Google Scholar
• Hosokawa Y, Hosokawa I, Ozaki K, et al. (2010). Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts. J Nutr Biochem, 21: 659–664.
   PubMed Web of Science ®Google Scholar
• Hosokawa Y, Hosokawa I, Shindo S, et al. (2015). Calcitriol suppressed inflammatory reactions in IL-1β-stimulated human periodontal ligament cells. Inflammation, 38, 2252–2258.
   PubMed Web of Science ®Google Scholar
• Jacobsen J, Nielsen EB, Brøndum-Nielsen K, et al. (1999). Filter-grown TR146 cells as an in vitro model of human buccal epithelial permeability. Eur J Oral Sci, 107, 138–146.
   PubMed Web of Science ®Google Scholar
• Kohli A, Islam A, Moyes DL, et al. (2014). Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected. Plos One, 9, e98077.
   PubMed Web of Science ®Google Scholar
• Li M, Liu X, Zhou Y, Su SB. (2009). Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses. J Leukoc Biol, 86, 23–32.
   PubMed Web of Science ®Google Scholar
• Li Y, Gao Q, Yuan X, et al. (2014). Adenovirus expressing IFN-λ1 (IL-29) attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma. Int Immunopharmacol, 21, 156–162.
   PubMed Web of Science ®Google Scholar
• Megjugorac NJ, Gallagher GE, Gallagher G. (2010). IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra. Blood 115, 4185–4190.
   PubMed Web of Science ®Google Scholar
• Melchjorsen J, Sirén J, Julkunen I, et al. (2006). Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J Gen Virol, 87, 1099–1108.
   PubMed Web of Science ®Google Scholar
• Pekarek V, Srinivas S, Eskdale J, Gallagher G. (2007). Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. Genes Immun, 8, 177–180.
   PubMed Web of Science ®Google Scholar
• Qian Z, Travanty EA, Oko L, et al. (2013). Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol, 48, 742–748.
   PubMed Web of Science ®Google Scholar
• Rajesh N, Arun KV, Kumar TS, et al. (2015). Evaluation of mRNA expression of the transcription factors of Th1 and Th2 subsets (T-bet and GATA-3) in periodontal health and disease – A pilot study in south Indian population. J Indian Soc Periodontol, 19, 624–627.
   PubMedGoogle Scholar
• Sauty A, Dziejman M, Taha RA, et al. (1999). The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol, 162, 3549–3558.
   PubMed Web of Science ®Google Scholar
• Sheppard P, Kindsvogel W, Xu W, et al. (2003). IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol, 4, 63–68.
   PubMed Web of Science ®Google Scholar
• Shivaprasad BM, Pradeep AR. (2013). Effect of non-surgical periodontal therapy on interleukin-29 levels in gingival crevicular fluid of chronic periodontitis and aggressive periodontitis patients. Dis Markers, 34, 1–7.
   PubMed Web of Science ®Google Scholar
• Sorenson BS, Khammanivong A, Guenther BD, et al. (2012). IL-1 receptor regulates S100A8/A9-dependent keratinocyte resistance to bacterial invasion. Mucosal Immunol, 5, 66–75.
   PubMed Web of Science ®Google Scholar
• Souza PP, Lerner UH. (2013). The role of cytokines in inflammatory bone loss. Immunol Invest, 42, 555–622.
   PubMed Web of Science ®Google Scholar
• Srinivas S, Dai J, Eskdale J, et al. (2008). Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology, 125, 492–502.
   PubMed Web of Science ®Google Scholar
• Taubman MA, Kawai T, 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med, 12, 125–135.
   PubMedGoogle Scholar
• Witte E, Kokolakis G, Witte K, et al. (2016). Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration. J Mol Med, 94, 391–400.
   PubMed Web of Science ®Google Scholar
• Witte K, Witte E, Sabat R, Wolk K. (2010). IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev, 21, 237–251.
   PubMed Web of Science ®Google Scholar
• Wolk K, Witte K, Witte E, et al. (2008). Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol, 83, 1181–1193.
   PubMed Web of Science ®Google Scholar
• Wu S, Xue J, Yang Y, et al. (2015). Isoliquiritigenin inhibits interferon-γ-inducible genes expression in hepatocytes through down-regulating activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt signaling pathways. Cell Physiol Biochem, 37, 501–514.
   PubMed Web of Science ®Google Scholar
• Xu D, Yan S, Wang H, et al. (2015). IL-29 enhances LPS/TLR4-mediated inflammation in rheumatoid arthritis. Cell Physiol Biochem, 37, 27–34.
   PubMed Web of Science ®Google Scholar
• Xu L, Feng X, Tan W, et al. (2013). IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients. Arthritis Res Ther, 15, R170.
   PubMed Web of Science ®Google Scholar
• Xu L, Peng Q, Xuan W, et al. (2016). Interleukin-29 enhances synovial inflammation and cartilage degradation in osteoarthritis. Mediators Inflamm, 2016, 9631510.
   PubMedGoogle Scholar
• Zaheer RS, Koetzler R, Holden NS, et al. (2009). Selective transcriptional down-regulation of human rhinovirus-induced production of CXCL10 from airway epithelial cells via the MEK1 pathway. J Immunol, 182, 4854–4864.
   PubMed Web of Science ®Google Scholar